share_log

Needham Reiterates Hold on Lexicon Pharmaceuticals

Benzinga ·  Apr 11 06:20

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment